Literature DB >> 22818410

[Evaluation and management of acute radiation dermatitis].

A Modesto1, J-C Faivre, F Granel-Brocard, Y-G Tao, Y Pointreau.   

Abstract

Acute radiation dermatitis remains one of the most commonly observed side effect during radiation therapy leading to complication such as superinfection or treatment disruption. Its management is characterized by a great heterogeneity. Few strategies have demonstrated a benefit in preventing radiation dermatitis, which relies mostly on decreasing dose delivered to the skin and skin care practices. Simple emollients and use of topical steroids can be useful in early stages. The singularity of the skin toxicity seen with cetuximab and radiotherapy warrants a specific grading system and distinctive clinical treatment with use of antibiotics.
Copyright © 2012 Société française de radiothérapie oncologique (SFRO). Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22818410     DOI: 10.1016/j.canrad.2012.05.007

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  2 in total

1.  Correlation between anthropometric parameters and acute skin toxicity in breast cancer radiotherapy patients: a pilot assessment study.

Authors:  Benoîte Méry; Alexis Vallard; Jane-Chloé Trone; Cécile Pacaut; Jean-Baptiste Guy; Sophie Espenel; Julien Langrand-Escure; Edouard Ollier; Guoping Wang; Peng Diao; Lise Bigot; Sylvie Mengue Ndong; Claire Bosacki; Majed Ben Mrad; Nicolas Magné
Journal:  Br J Radiol       Date:  2015-09-22       Impact factor: 3.039

2.  Randomized, self-controlled, prospective assessment of the efficacy of mometasone furoate local application in reducing acute radiation dermatitis in patients with head and neck squamous cell carcinomas.

Authors:  Yao Liao; Gang Feng; Tangzhi Dai; Fengjiao Long; Junfei Tang; Yuanxue Pu; Xuhai Zheng; Sui Cao; Shan Xu; Xiaobo Du
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.